Vitreous and Retina

  • Ferenc Kuhn
Chapter

Abstract

In most cases the condition of the retina determines the outcome of an injury. In all cases of ocular (or systemic; see Chap. 3.3) trauma when posterior segment involvement can be suspected, vitreoretinal consultation should be sought. The earlier such consultation takes place the better. Many vitreoretinal surgeons also prefer if they are the one who sutures the corneal/scleral wound so that optimal conditions are established for vitrectomy, which may have be to performed in a very short period of time if this is deemed necessary to prevent secondary complications.

Keywords

Retinal Detachment Macular Hole Vitreous Hemorrhage Posterior Vitreous Detachment Scleral Buckle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Abrams G, Azen S, McCuen B, Flynn H, Lai M, Ryan S (1997) Vitrectomy with silicone oil or perfluorocarbon gas in eyes with severe PVR. Results of additional and long-term follow-up. Arch Ophthalmol 115: 335−344PubMedGoogle Scholar
  2. [2]
    Alameri A, Baker NS (2005) Successful use of recombinant activated factor VII in the treatment of vitreous haemorrhage: a report of seven cases. Blood Coagul Fibrinolysis 16: 573−578PubMedCrossRefGoogle Scholar
  3. [3]
    Allinson RW (2002) Adjuvant 5-FU and heparin prevent PVR. Ophthalmology 109: 829−830; author reply 830PubMedCrossRefGoogle Scholar
  4. [4]
    Aralikatti AK, Haridas AS, Smith JM (2006) Delayed Nd:YAG laser membranotomy for traumatic premacular hemorrhage. Arch Ophthalmol 124: 1503PubMedCrossRefGoogle Scholar
  5. [5]
    Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology 108: 1179−1183PubMedCrossRefGoogle Scholar
  6. [6]
    Asaria RH, Zaman A, Sullivan PM (1999) Retinitis sclopetaria associated with airbag inflation. Br J Ophthalmol 83: 1094−1095PubMedGoogle Scholar
  7. [7]
    Bartz-Schmidt KU, Kirchhof B, Heimann K (1996) Risk factors for retinal redetachment by proliferative vitreoretinopathy after episcleral surgery for pseudophakic retinal detachment. Klin Monatsbl Augenheilkd 208: 82−86 [in German]PubMedGoogle Scholar
  8. [8]
    Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107: 2010−2014PubMedCrossRefGoogle Scholar
  9. [9]
    Campochiaro PA, Gaskin HC, Vinores SA (1987) Retinal cryopexy stimulates traction retinal detachment in the presence of an ocular wound. Arch Ophthalmol 1567−1570Google Scholar
  10. [10]
    Capeans C, Lorenzo J, Santos L, Suarez A, Copena MJ, Blanco MJ, Sanchez-Salorio M (1998) Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefe’s Arch Clin Exp Ophthalmol 236: 481−485CrossRefGoogle Scholar
  11. [11]
    Cardillo JA, Stout JT, LaBree L, Azen SP, Omphroy L, Cui JZ, Kimura H, Hinton DR, Ryan SJ (1997) Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104: 1166−1173PubMedGoogle Scholar
  12. [12]
    Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C (2004) A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 111: 2240−2245PubMedCrossRefGoogle Scholar
  13. [13]
    Chaudhry N, Mieler W, Han D, Alfaro V, Liggett P (1999) Preoperative use of tissue plasminogen activator for large submacular hemorrhage. Ophthalmic Surg Lasers 30: 176−180PubMedGoogle Scholar
  14. [14]
    Cibis P, Yamashita T, Rodriguez F (1959) Clinical aspects of ocular siderosis and hemosiderosis. Arch Ophthalmol 62: 46−53Google Scholar
  15. [15]
    Clarkson JG, Flynn HW, Daily MJ (1980) Vitrectomy in Terson’s syndrome. Am J Ophthalmol 90: 540−552Google Scholar
  16. [16]
    Cleary PE, Ryan SJ (1979) Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey. Am J Ophthalmol 88: 212−220PubMedGoogle Scholar
  17. [17]
    Cleary PE, Ryan SJ (1981) Vitrectomy in penetrating eye injury. Arch Ophthalmol 99: 287−292PubMedGoogle Scholar
  18. [18]
    Coleman D (1982) Early vitrectomy in the management of the severely traumatized eye. Am J Ophthalmol 93: 543−551PubMedGoogle Scholar
  19. [19]
    Conway MD, Peyman GA, Recasens M (1999) Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome. Ophthalmic Surg Lasers 30: 435−441PubMedGoogle Scholar
  20. [20]
    Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107: 1147−1151PubMedGoogle Scholar
  21. [21]
    Cox MS, Schepens CL, Freeman HM (1966) Retinal detachment due to ocular contusion. Arch Ophthalmol 76: 678−685PubMedGoogle Scholar
  22. [22]
    Coyler M, Weber E, Weichel E, Dick J, Bower K, Ward T, Haller J (in press) Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi and Enduring Freedom. OphthalmologyGoogle Scholar
  23. [23]
    De Pool ME, Campbell JP, Broome SO, Guyton DL (2005) The dragged-fovea diplopia syndrome: clinical characteristics, diagnosis, and treatment. Ophthalmology 112: 1455−1462PubMedCrossRefGoogle Scholar
  24. [24]
    Dellaporta AN (1994) Evacuation of subretinal hemorrhage. Int Ophthalmol 18: 25−31PubMedCrossRefGoogle Scholar
  25. [25]
    Desai UR (1995) Spontaneous vitreous base avulsion in a patient with neurofibromatosis. Indian J Ophthalmol 43: 33PubMedGoogle Scholar
  26. [26]
    Desatnik H, Treister G, Moisseiev J (1999) Spontaneous separation of an idiopathic macular pucker in a young girl. Am J Ophthalmol 127: 729−731PubMedCrossRefGoogle Scholar
  27. [27]
    Dong X, Chen N, Xie L, Wang S (2006) Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid. Retina 26: 210−213PubMedCrossRefGoogle Scholar
  28. [28]
    Dumas C, Bonnet M (1996) Choroidal detachment associated with rhegmatogenous retinal detachment: a risk factor for postoperative PVR?. J Fr Ophtalmol 19: 455−463PubMedGoogle Scholar
  29. [29]
    Durukan AH, Kerimoglu H, Erdurman C, Demirel A, Karagul S (2006) Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. EyeGoogle Scholar
  30. [30]
    Ehrenberg M, Tresher RJ, Machemer R (1984) Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation. Am J Ophthalmol 97: 611−626PubMedGoogle Scholar
  31. [31]
    Engelbrecht N, Freeman J, Sternberg PJ, Aaberg TS, Aaberg TJ, Martin D, Sippy B (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 89−94Google Scholar
  32. [32]
    Er H, Turkoz Y, Mizrak B, Parlakpinar H (2006) Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Ophthalmologica 220: 17−22PubMedCrossRefGoogle Scholar
  33. [33]
    Ersanli D, Sonmez M, Unal M, Gulecek O (2006) Management of retinal detachment due to closed globe injury by pars plana vitrectomy with and without scleral buckling. Retina 26: 32−36PubMedCrossRefGoogle Scholar
  34. [34]
    Fraser EA, Cheema RA, Roberts MA (2003) Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery. Retina 23: 883−884PubMedCrossRefGoogle Scholar
  35. [35]
    Girard P, Mimoun G, Karpouzas I, Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14: 417−424PubMedCrossRefGoogle Scholar
  36. [36]
    Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94: 762−773PubMedCrossRefGoogle Scholar
  37. [37]
    Guigon-Souquet B, Salaun N, Macarez R, Bazin S, De La Marnierre E, Mazdou M (2004) Subhyaloid hemorrhage following a Valsalva maneuver. J Fr Ophtalmol 27: 1159−1162 [in French]PubMedGoogle Scholar
  38. [38]
    Halberstadt M, Domig D, Kodjikian L, Koerner F, Garweg JG (2006) PVR recurrence and the timing of silicon oil removal. Klin Monatsbl Augenheilkd 223: 361−366PubMedCrossRefGoogle Scholar
  39. [39]
    Hermsen V (1984) Vitrectomy in severe ocular trauma. Ophthalmologica 189: 86−92PubMedCrossRefGoogle Scholar
  40. [40]
    Hesse L, Bodanowitz S, Kroll P (1996) Retinal necrosis after blunt bulbus trauma. Klin Monatsbl Augenheilkd 209: 150−152 [in German]PubMedGoogle Scholar
  41. [41]
    Horio N, Horiguchi M (2004) Retinal blood flow analysis using intraoperative video fluorescein angiography combined with optical fiber-free intravitreal surgery system. Am J Ophthalmol 138: 1082−1083PubMedCrossRefGoogle Scholar
  42. [42]
    Isernhagen RD, Smiddy WE, Michels RG (1988) Vitrectomy for nondiabetic vitreous hemorrhage. Not associated with vascular disease. Retina 8: 81−87PubMedGoogle Scholar
  43. [43]
    Ismail R, Tanner V, Williamson TH (2002) Optical coherence tomography imaging of severe commotio retinae and associated macular hole. Br J Ophthalmol 86: 473−474PubMedCrossRefGoogle Scholar
  44. [44]
    Kennedy C, Parker C, McAllister I (1997) Retinal detachment caused by retinal dialysis. Aust N Z J Ophthalmol 251: 25−30CrossRefGoogle Scholar
  45. [45]
    Kishi S, Hagimura N, Shimizu K (1996) The role of the premacular liquefied pocket and premacular vitreous complex in idiopathic macular hole development. Am J Ophthalmol 122: 622−628PubMedGoogle Scholar
  46. [46]
    Koh HJ, Kim SH, Lee SC, Kwon OW (2000) Treatment of subhyaloid haemorrhage with intravitreal tissue plasminogen activator and C3F8 gas injection. Br J Ophthalmol 84: 1329−1330PubMedCrossRefGoogle Scholar
  47. [47]
    Kuhn F, Kiss G, Mester V, Szijarto Z, Kovacs B (2004) Vitrectomy with internal limiting membrane removal for clinically significant macular edema. Graefe’s Arch Clin Exper Ophthal 242: 402−408CrossRefGoogle Scholar
  48. [48]
    Kuhn F, Mester V, Berta A (1998) The Tano diamond dusted membrane scraper: indications and contraindications. Acta Ophthalmol 76: 754−756CrossRefGoogle Scholar
  49. [49]
    Kuhn F, Mester V, Morris R (2004) A proactive treatment approach for eyes with perforating injury. Klin Monatsbl Augenheilk 221: 622−628CrossRefGoogle Scholar
  50. [50]
    Kuhn F, Morris R, Mester V, Witherspoon C (1998) Terson’s syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology 105: 472−477PubMedCrossRefGoogle Scholar
  51. [51]
    Kuhn F, Morris R, Mester V, Witherspoon C (2000) Internal limiting membrane removal for traumatic macular holes. Ophthalmol Surg Laser 31: 308−315Google Scholar
  52. [52]
    Kuppermann BD, Thomas EL, de Smet MD, Grillone LR (2005) Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140: 573−584PubMedCrossRefGoogle Scholar
  53. [53]
    Kuriyama S, Ohuchi T, Yoshimura N, Honda Y, Hiraoka M, Abe M (1990) Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits. Graefe’s Arch Clin Exp Ophthalmol 228: 552−555CrossRefGoogle Scholar
  54. [54]
    Lemor M, Yeo JH, Glaser BM (1986) Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 104: 1226−1229PubMedGoogle Scholar
  55. [55]
    Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J (2003) Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 87: 216−219PubMedCrossRefGoogle Scholar
  56. [56]
    Liggett P, Gauderman W, Moreira C, Barlow W, Green R, Ryan S (1990) Pars plana vitrectomy for acute retinal detachment in penetrating ocular injuries. Arch Ophthalmol 108: 1724−1728PubMedGoogle Scholar
  57. [57]
    Lincoff H, Madjarov B, Lincoff N, Movshovich A, Saxena S, Coleman DJ, Schubert H, Rosberger D, McCormick S (2003) Pathogenesis of the vitreous cloud emanating from subretinal hemorrhage. Arch Ophthalmol 121: 91−96PubMedGoogle Scholar
  58. [58]
    Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77: 171−180PubMedGoogle Scholar
  59. [59]
    Majid MA, Hussain HM, Haynes RJ, Dick AD (2006) Buckle, no cryo: scleral buckle with no cryotherapy for retinal detachment secondary to commotio retinae. Br J Ophthalmol 90: 1550−1551PubMedCrossRefGoogle Scholar
  60. [60]
    Matsumoto C, Arimura E, Okuyama S, Takada S, Hashimoto S, Shimomura Y (2003) Quantification of metamorphopsia in patients with epiretinal membranes. Invest Ophthalmol Vis Sci 44: 4012−4016PubMedCrossRefGoogle Scholar
  61. [61]
    Miller-Meeks MJ, Bennett SR, Keech RV, Blodi CF (1990) Myopia induced by vitreous hemorrhage. Am J Ophthalmol 109: 199−203PubMedGoogle Scholar
  62. [62]
    Morris R, Kuhn F (1998) Surgical treatment of macular surface disorders. Highlights of Ophthalmology International, Panama City, pp 58−64Google Scholar
  63. [63]
    Morris R, Kuhn F, Mester V (2000) Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole. Br J Ophthalmol 84: 673PubMedCrossRefGoogle Scholar
  64. [64]
    Morris R, Kuhn F, Witherspoon C (1993) Hemorrhagic macular cysts. Ophthalmology 100: 1Google Scholar
  65. [65]
    Morris R, Kuhn F, Witherspoon C (1994) Retinal folds and hemorrhagic macular cysts in Terson’s syndrome. Ophthalmology 101: 1PubMedGoogle Scholar
  66. [66]
    Moshfeghi AA, Harrison SA, Reinstein DZ, Ferrone PJ (2006) Valsalva-like retinopathy following hyperopic laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging 37: 486−488PubMedGoogle Scholar
  67. [67]
    Munir WM, Pulido JS, Sharma MC, Buerk BM (2005) Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol 40: 598−604PubMedGoogle Scholar
  68. [68]
    O’Hanley GP, Canny CL (1985) Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology 92: 507−511PubMedGoogle Scholar
  69. [69]
    Park SW, Seo MS (2004) Subhyaloid hemorrhage treated with SF6 gas injection. Ophthalmic Surg Lasers Imaging 35: 335−337PubMedGoogle Scholar
  70. [70]
    Puustjarvi TJ, Terasvirta ME (2001) Retinal fixation of traumatic retinal detachment with metallic tacks: a case report with 10 years’ follow-up. Retina 21: 54−56PubMedCrossRefGoogle Scholar
  71. [71]
    Richards R, West C, Meisels A (1968) Chorioretinitis sclopetaria. Trans Am Ophthalmol Soc 66: 214−232PubMedGoogle Scholar
  72. [72]
    Sandner D, Herbrig E, Engelmann K (2007) High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefe’s Arch Clin Exp OphthalmolGoogle Scholar
  73. [73]
    Schmidt JG (1987) Intravitreal cupriferous foreign bodies: electroretinograms and inflammatory responses. Doc Ophthalmol 67: 253−261PubMedCrossRefGoogle Scholar
  74. [74]
    Sebag J (2005) Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 103: 473−494PubMedGoogle Scholar
  75. [75]
    Shinohara K, Tanaka M, Sakuma T, Kobayashi Y (2003) Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging 34: 299−305PubMedGoogle Scholar
  76. [76]
    Sipperley JO, Quigley HA, Gass DM (1978) Traumatic retinopathy in primates. The explanation of commotio retinae. Arch Ophthalmol 96: 2267−2273PubMedGoogle Scholar
  77. [77]
    Skorpik C, Menapace R, Gnad HD, Paroussis P (1989) Silicone oil implantation in penetrating injuries complicated by PVR. Results from 1982 to 1986. Retina 9: 8−14PubMedCrossRefGoogle Scholar
  78. [78]
    Spraul CW, Grossniklaus HE (1997) Vitreous hemorrhage. Surv Ophthalmol 42: 3−39PubMedCrossRefGoogle Scholar
  79. [79]
    Sternberg P Jr, Han DP, Yeo JH, Barr CC, Lewis H, Williams GA, Mieler WF (1988) Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology 95: 1389−1393PubMedGoogle Scholar
  80. [80]
    Stone TW, Siddiqui N, Arroyo JG, McCuen BW 2nd, Postel EA (2000) Primary scleral buckling in open-globe injury involving the posterior segment. Ophthalmology 107: 1923−1926PubMedCrossRefGoogle Scholar
  81. [81]
    Tanaka M, Qui H (2000) Pharmacological vitrectomy. Semin Ophthalmol 15: 51−61PubMedGoogle Scholar
  82. [82]
    Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112: 1574PubMedCrossRefGoogle Scholar
  83. [83]
    Trese MT (2000) Enzymatic vitreous surgery. Semin Ophthalmol 15: 116−121PubMedCrossRefGoogle Scholar
  84. [84]
    Ullern M, Roman S, Dhalluin JF, Lozato P, Grillon S, Bellefqih S, Cambourieu C, Baudouin C (2002) Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study. J Fr Ophtalmol 25: 915−920 [in French]PubMedGoogle Scholar
  85. [85]
    van Bockxmeer FM, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26: 1140−1147PubMedGoogle Scholar
  86. [86]
    Wallace R, McNamara J, Brown G, Benson W, Belmont J, Goldberg R, Federman J (1993) The use of perfluorophenanthrene in the removal of intravitreal lens fragments. Am J Ophthalmol 116: 196−200PubMedGoogle Scholar
  87. [87]
    Weidenthal D, Schepens C (1966) Peripheral fundus changes associated with ocular contusion. Am J Ophthalmol 62: 465PubMedGoogle Scholar
  88. [88]
    Wickham L, Xing W, Bunce C, Sullivan P (2006) Outcomes of surgery for posterior segment intraocular foreign bodies-a retrospective review of 17 years of clinical experience. Graefe’s Arch Clin Exp OphthalmolGoogle Scholar
  89. [89]
    Wiedemann P, Lemmen K, Schmiedl R, Heimann K (1987) Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 104: 10−14PubMedGoogle Scholar
  90. [90]
    Williams RG, Chang S, Comaratta MR, Simoni G (1996) Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefe’s Arch Clin Exp Ophthalmol 234: 496−503CrossRefGoogle Scholar
  91. [91]
    Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23: 335−342PubMedCrossRefGoogle Scholar
  92. [92]
    Yamada H, Sakai A, Yamada E, Nishimura T, Matsumura M (2002) Spontaneous closure of traumatic macular hole. Am J Ophthalmol 134: 340−347PubMedCrossRefGoogle Scholar
  93. [93]
    Yanoff M (1975) Pathology of cataract. In: Bellows JG (eds) Cataract and abnormalities of the lens. Grune and Stratton, New York, pp 179Google Scholar
  94. [94]
    Morris R et al. (2006) Prophylactic silicone oil placement for retinal detachments with grades A and B PVR. Association for Research and Vision in Ophthalmology, Fort LauderdaleGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Ferenc Kuhn
    • 1
  1. 1.University of Alabama at BirminghamBirminghamUSA

Personalised recommendations